Manson AJ[au] - Search Results

Year	Number of Results
1963	1
1967	1
1987	1
1989	1
2000	4
2001	2
2002	1
2004	1
2005	1
2024	0

1

Low-dose olanzapine for levodopa induced dyskinesias.

Manson AJ, Schrag A, Lees AJ. Manson AJ, et al. Neurology. 2000 Sep 26;55(6):795-9. doi: 10.1212/wnl.55.6.795. Neurology. 2000. PMID: 10993998 Clinical Trial.

2

An ambulatory dyskinesia monitor.

Manson AJ, Brown P, O'Sullivan JD, Asselman P, Buckwell D, Lees AJ. Manson AJ, et al. J Neurol Neurosurg Psychiatry. 2000 Feb;68(2):196-201. doi: 10.1136/jnnp.68.2.196. J Neurol Neurosurg Psychiatry. 2000. PMID: 10644787 Free PMC article. Clinical Trial.

3

High dose naltrexone for dyskinesias induced by levodopa.

Manson AJ, Katzenschlager R, Hobart J, Lees AJ. Manson AJ, et al. J Neurol Neurosurg Psychiatry. 2001 Apr;70(4):554-6. doi: 10.1136/jnnp.70.4.554. J Neurol Neurosurg Psychiatry. 2001. PMID: 11254789 Free PMC article.

4

Idazoxan is ineffective for levodopa-induced dyskinesias in Parkinson's disease.

Manson AJ, Iakovidou E, Lees AJ. Manson AJ, et al. Mov Disord. 2000 Mar;15(2):336-7. doi: 10.1002/1531-8257(200003)15:2<336::aid-mds1023>3.0.co;2-r. Mov Disord. 2000. PMID: 10752589 Clinical Trial. No abstract available.

5

Intravenous apomorphine therapy in Parkinson's disease: clinical and pharmacokinetic observations.

Manson AJ, Hanagasi H, Turner K, Patsalos PN, Carey P, Ratnaraj N, Lees AJ. Manson AJ, et al. Brain. 2001 Feb;124(Pt 2):331-40. doi: 10.1093/brain/124.2.331. Brain. 2001. PMID: 11157560 Clinical Trial.

6

STEROIDAL HETEROCYCLES. VII. ANDROSTANO(2,3-D)ISOXAZOLES AND RELATED COMPOUNDS.

MANSON AJ, STONNER FW, NEUMANN HC, CHRISTIANSEN RG, CLARKE RL, ACKERMAN JH, PAGE DF, DEAN JW, PHILLIPS DK, POTTS GO, ARNOLD A, BEYLER AL, CLINTON RO. MANSON AJ, et al. J Med Chem. 1963 Jan;6:1-9. doi: 10.1021/jm00337a001. J Med Chem. 1963. PMID: 14174022 No abstract available.

7

Low dose quetiapine for drug induced dyskinesias in Parkinson's disease: a double blind cross over study.

Katzenschlager R, Manson AJ, Evans A, Watt H, Lees AJ. Katzenschlager R, et al. Among authors: manson aj. J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):295-7. J Neurol Neurosurg Psychiatry. 2004. PMID: 14742609 Free PMC article. Clinical Trial.

8

Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients.

Manson AJ, Turner K, Lees AJ. Manson AJ, et al. Mov Disord. 2002 Nov;17(6):1235-41. doi: 10.1002/mds.10281. Mov Disord. 2002. PMID: 12465062

9

Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges.

Katzenschlager R, Hughes A, Evans A, Manson AJ, Hoffman M, Swinn L, Watt H, Bhatia K, Quinn N, Lees AJ. Katzenschlager R, et al. Among authors: manson aj. Mov Disord. 2005 Feb;20(2):151-7. doi: 10.1002/mds.20276. Mov Disord. 2005. PMID: 15390035 Clinical Trial.

10

A rapid, qualitative ELISA test for the specific detection of morphine in serum or urine.

Laurie D, Manson AJ, Rowell FJ, Seviour J. Laurie D, et al. Among authors: manson aj. Clin Chim Acta. 1989 Aug 15;183(2):183-95. doi: 10.1016/0009-8981(89)90334-3. Clin Chim Acta. 1989. PMID: 2791304

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year